# Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections

> **NCT05606159** · NA · WITHDRAWN · sponsor: **Novozymes A/S**

## Conditions studied

- Clostridium Difficile Infection Recurrence

## Interventions

- **DIETARY_SUPPLEMENT:** Bacillus velezensis DSM 33864
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05606159
- **Lead sponsor:** Novozymes A/S
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Research Project closed
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05606159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05606159, "Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05606159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*